|
|
|
|
| LEADER |
03394nam a22003255i 4500 |
| 001 |
000292316 |
| 005 |
20210614145930.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120627s2012 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781617799211
|
| 024 |
7 |
|
|a 10.1007/978-1-61779-921-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Therapeutic Proteins :
|b Methods and Protocols /
|c edited by Vladimir Voynov, Justin A. Caravella.
|
| 250 |
|
|
|a 2nd ed. 2012.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2012.
|
| 300 |
|
|
|a XI, 502 p. 107 illus., 50 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Biology,
|v 899
|
| 505 |
0 |
|
|a Therapeutic Proteins -- Synthetic Antibody Libraries -- The Construction of ‘Phylomer’ Peptide Libraries as a Rich Source of Potent Inhibitors of Protein/Protein Interactions -- Ribosome Display and Screening for Protein Therapeutics -- Yeast Display of Engineered Antibody Domains -- Design, Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains -- Engineering of Affibody Molecules for Therapy and Diagnostics -- Protein Design for Diversity of Sequences and Conformations Using Dead-End Elimination -- Design and Generation of DVD-IgTM Molecules for Dual-Specific Targeting -- Engineering and Expression of Bibody and Tribody Constructs in Mammalian Cells and in the Yeast Pichia pastoris -- Use of E. coli for the Production of a Single Protein -- Folding Engineering Strategies for Efficient Membrane Protein Production in E. coli -- Transient Expression Technologies: Past, Present, and Future -- Stable Transfection Pools for Large Quantity of Protein Production -- Mammalian Stable Expression of Biotherapeutics -- Transgenic Expression of Therapeutic Proteins in Arabidopsis thaliana Seed -- Methods for Chromatographic Removal of Endotoxin -- Effectiveness of Various Processing Steps for Viral Clearance of Therapeutic Proteins: Database Analyses of Commonly-Used Steps -- High-Throughput Quantitative N-Glycan Analysis of Glycoproteins -- High-Throughput Multimodal Strong Anion Exchange Purification and N-Glycan Characterization of Endogenous Glycoprotein Expressed in Glycoengineered Pichia pastoris -- Databases and Tools in Glycobiology -- Characterization of PEGylated Biopharmaceutical Products by LC/MS and LC/MS/MS -- Identification of Asp Isomerization in Proteins by 18O Labeling and Tandem Mass Spectrometry -- Monitoring of Subvisible Particles in Therapeutic Proteins -- Size-Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS) for Elucidating Protein Aggregation Mechanisms -- Computational Methods to Predict Therapeutic Protein Aggregation -- Coarse-Grained Simulations of Protein Aggregation -- Chitosan-Based Nanoparticles as Delivery Systems of Therapeutic Proteins -- Challenges in the Development and Manufacturing of Antibody-Drug Conjugates.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Proteomics.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Proteomics.
|
| 700 |
1 |
|
|a Voynov, Vladimir.
|e editor.
|
| 700 |
1 |
|
|a Caravella, Justin A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|